News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- Opinion: FDA is smashing the status quo for regulatory science
- Opinion: Accounting for hope: using ‘mean survival gain’ to price new cancer drugs
- An updated guide to the changing science of flu shots
- FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
- Lilly's 1-drug migraine business gets support with new approval
- Lilly scores FDA nod for new migraine drug Reyvow
- Vaping-related illness has a new name: EVALI
- Sun Pharma is accused of distributing medicines in Washington state without a license
- On second thought, AbbVie's new arthritis drug not so costly, ICER says
- Five Prime's restructuring claims more jobs
- Koalas shed light on DNA’s ability to resist cancer-causing viruses
- STAT Plus: UCB’s $2.5 billion purchase of Ra Pharma underscores immunology focus
- Poseida Therapeutics Brings In Amgen’s Kerry Ingalls as COO
- ICER says AbbVie's Rinvoq for RA may be cost-effective but still questions the value of JAK class
- Johnson & Johnson, besieged by lawsuits, could be a steal for investors: analyst